Skip to Content

Evoqua Water Technologies Corp.

Merger

  • Date:
  • 1/23/2023
  • Company Name:
  • Evoqua Water Technologies Corp.
  • Stock Symbol:
  • AQUA
  • Company Name - Buyer:
  • Xylem Inc.
  • Stock Symbol - Buyer:
  • XYL
  • Status:
  • Investigating
  • Merger Announcement Date:
  • 1/23/2023

Case Finder

Locate any case using the tools below.

NEW YORK, January 23, 2023 – Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of Evoqua Water Technologies Corp. (NYSE: AQUA) (“Evoqua”) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by Xylem Inc. (NYSE: XYL) (“Xylem”).

On January 23, 2023, Evoqua announced that it had entered into an agreement to be acquired by Sun Pharma in a $7.5 billion all-stock deal. Pursuant to the merger agreement, Evoqua shareholders will receive 0.480 shares of Xylem for each Evoqua share. The deal is expected to close in mid-2023.

Bragar Eagel & Squire is concerned that Evoqua’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Evoqua’s stockholders.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Evoqua Water Technologies Corp.. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: